DESCRIPTION

The NOSEVAC project aims at developing and evaluating innovative nasal vaccine platforms as a novel approach to prevent the earliest stage of infection, thereby inhibiting upper respiratory tract (URT) colonisation, transmission and disease.
Under the European Vaccine Initiative (EVI) coordination, the NOSEVAC project builds on a unique consortium of 13 complementary teams from the EU, UK and Switzerland.
(https://www.nosevac-project.eu)